Arcadia Biosciences, Inc.
RKDA
$1.12
$0.076.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 67.13% | 153.10% | -520.17% | 207.26% | -42.45% |
| Total Depreciation and Amortization | -98.83% | -95.54% | -86.60% | -48.68% | -22.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -101.44% | -3,262.07% | 185.17% | -764.03% | 804.25% |
| Change in Net Operating Assets | 207.01% | 447.28% | -377.54% | -17.22% | 61.01% |
| Cash from Operations | 61.02% | 85.33% | 17.22% | 50.53% | 46.71% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -110.96% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -- | -94.45% | -- | 12,114.29% |
| Cash from Investing | -100.00% | -100.00% | -94.62% | 12,400.00% | 4,736.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -75.00% | -- | 0.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -75.00% | -- | 0.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -381.37% | 83.67% | -181.53% | 66.17% | 107.48% |